Changes in and discrepancies between cell tropisms and coreceptor uses of human immunodeficiency virus type 1 induced by single point mutations at the V3 tip of the Env protein

Virology

Volumn 259, Issue 2, 1999, Pages 324-333

  Shimizu, Nobuaki ^a   Haraguchi, Yuji ^a   Takeuchi, Yasuhiro ^a,b   Soda, Yasushi ^a,c   Kanbe, Katsuaki ^a   Hoshino, Hiroo ^a  

^a GUNMA UNIVERSITY   (Japan)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c The Japan Foundation   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; VIRUS ENVELOPE PROTEIN; VIRUS RECEPTOR;

AMINO ACID SUBSTITUTION; ARTICLE; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MACROPHAGE; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; STRAIN DIFFERENCE; VIRUS CELL INTERACTION; VIRUS ENVELOPE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0033526829     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9764     Document Type: Article

References (40)

1. Atwood W. J., Berger J. R., Kaderman R., Tornatore C. S., Major E. O. Human immunodeficiency virus type 1 infection of the brain. Clin. Microbiol. Rev. 6:1993;339-366.
2. Cann A. J., Churcher M. J., Boyd M., O'Brien W., Zhao J. Q., Zack J., Chen I. S. Y. The region of the envelope gene of human immunodeficiency virus type 1 responsible for determination of cell tropism. J. Virol. 66:1992;305-309.
3. Chesebro B., Wehrly K., Nishio J., Perryman S. Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: Definition of critical amino acids involved in cell tropism. J. Virol. 66:1992;6547-6554.
4. Choe H., Farzan M., Sun Y., Sullivan N., Rollins B., Ponath P. D., Wu L., Mackay C. R., LaRosa G., Newman W., Berard N. G., Gerard C., Sodroski J. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell. 85:1996;1135-1148.
5. Dalgleish A. G., Beverley P. C., Clapham P. R., Crawfold D. H., Greaves M. F., Weiss R. A. The CD4 T4 antigen is an essential component of the receptor for the AIDS retrovirus. Nature. 312:1984;763-767.
6. Ebenbichler S., Westervelt O., Carrillo A., Henkel T., Johnson D., Ratner L. Structure-function relationships of the HIV-1 envelope V3 loop tropism determinant: Evidence for two distinct conformations. AIDS. 7:1993;639-646.
7. Epstein L. G., Gendelman H. E. Human immunodeficiency virus type 1 infection of the nervous system: Pathogenetic mechanisms. Ann. Neurol. 33:1993;429-436.
8. Feng Y., Broder C. C., Kennedy P. E., Berger E. A. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science. 272:1996;872-877.
9. Goudsmit J., Debouck C., Meloen R. H., Shmit L., Bakker M., Asher D. M., Wolff A. V., Gibbs C. J. J., Gajdusek D. C. Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees. Proc. Natl. Acad. Sci. USA. 85:1988;4478-4482.
10. Haraguchi Y., Takeuchi Y., Hoshino H. Inhibition of plating of human T cell leukemia virus type 1 and syncytium-inducing types of human immunodeficiency virus type 1 by polycations. AIDS Res. Hum. Retroviruses. 13:1997;1517-1523.
11. Hasan M., Glees P. The fine structure of human cerebral perivascular pericytes and juxtavascular phagocytes: Their possible role in hydrocephalic edema resolution. J. Hirnforsch. 31:1990;237-249.
12. Hoshino H., Esumi H., Miwa M., Shimoyama M., Minato K., Tobinai K., Hirose M., Watanabe S., Inada N., Kinoshita K., Kamihira S., Ichimaru M., Sugimura T. Establishment and characterization of 10 cell lines derived from patients with adult T-cell leukemia. Proc. Natl. Acad. Sci. USA. 80:1983;6061-6065.
13. Hwang S. S., Boyle T. J., Lyerly H. K., Cullen B. R. Identification of envelope V3 loop as the major determinant of CD4 neutralization sensitivity of HIV-1. Science. 257:1992;535-537.
14. Jinno A., Shimizu N., Soda Y., Haraguchi Y., Kitamura T., Hoshino H. Identification of the chemokine receptor TER1/CCR8 expressed in brain-derived cells and T cells as a new coreceptor for HIV-1 infection. Biochem. Biophys. Res. Commun. 243:1998;497-502.
15. Katoh K., Takahashi Y., Hayashi S., Kondoh H. Improved mammalian vectors for high expression of G418 resistance. Cell Struct. Funct. 12:1987;575-580.
16. Korber B. T., Kunstman K. J., Patterson B. K., Furtado M., McEvilly M. M., Levy R., Wolinsky S. M. Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: Evidence of conserved elements in the V3 region of the envelope protein of brain derived sequences. J. Virol. 68:1994;7467-7481.
17. Liu Z. Q., Wood C., Levy J. A., Cheng-Mayer C. The viral envelope gene is involved in macrophage tropism of a human immunodeficiency virus type 1 strain isolated from brain tissue. J. Virol. 64:1990;6148-6153.
18. McKeating J. A., Gow J., Goudsmit J., Pearl J. H., Mulder C., Weiss R. A. Characterization of HIV-1 neutralization escape mutants. AIDS. 3:1989;777-784.
19. McKnight A., Weiss R. A., Shotton C., Takeuchi Y., Hoshino H., Clapham P. R. Change in tropism upon immune escape by human immunodeficiency virus. J. Virol. 69:1995;3167-3170.
20. McNearney T., Hornickova Z., Markham R., Birdwell A., Arens M., Saah A., Ratner L. Relationship of human immunodeficiency virus type 1 sequence heterogeneity to stage of disease. Proc. Natl. Acad. Sci. USA. 89:1992;10247-10251.
21. Miyata T., Miyazawa S., Yasunaga T. Two types of amino acid substitutions in protein evolution. J. Mol. Evol. 12:1979;219-236.
22. Monken C. E., Wu B., Srinivasan A. High resolution analysis of HIV-1 quasispecies in the brain. AIDS. 9:1995;345-349.
23. Oravecz T., Pall M., Norcross M. A. Beta-chemokine inhibition of monocytotropic HIV-1 infection: Interference with a postbinding fusion step. J. Immunol. 157:1996;1329-1332.
24. Persidsky Y., Stins M., Way D., Witte M. H., Weinand M., Kim K. S., Bock P., Gendelman H. E., Fiala M. A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis. J. Immunol. 158:1997;3499-3510.
25. Peudenier S., Hery C., Montagnier L., Tardieu M. Human microglial cells: Characterization in cerebral tissue and in primary culture, and study of their susceptibility to HIV-1 infection. Ann. Neurol. 29:1991;152-161.
26. Premack B. A., Schall T. G. Chemokine receptors: Gateway to inflammation and infection. Nat. Med. 2:1996;1174-1178.
27. Salahuddin S. Z., Markham P. D., Wang-Staal F., Franchini G., Kalyanaraman V. S., Gallo R. C. Restricted expression of human T-cell leukemia-lymphoma virus HTLV in transformed human umbilical cord blood lymphocytes. Virology. 129:1983;51-54.
28. Shimizu S. N., Shimizu N. G., Takeuchi Y., Hoshino H. Isolation and characterization of human immunodeficiency virus type 1 variants infectious to brain-derived cells: Detection of common point mutations in the V3 region of the env gene of the variants. J. Virol. 68:1994;6130-6135.
29. Shimizu N., Kobayashi M., Liu H-Y., Kido H., Hoshino H. Detection of tryptase TL2 and CD26 antigen in brain-derived cells non-permissive to T-cell line-tropic human immunodeficiency virus type 1. FEBS Lett. 358:1995;48-52.
30. Shimizu, N, Soda, Y, Kanbe, K, Jinno, A, Kitamura, T, and, Hoshino, H. An orphan G protein-coupled receptor, GPR1, acts as a co-receptor allowing replication of human immunodeficiency virus type 1 and type 2 in brain-derived cells, J. Virol, in press.
31. Shioda T., Oka S., Ida S., Nokihara K., Toriyoshi H., Mori S., Takebe Y., Kimura S., Shimada K., Nagai Y. A naturally occurring single basic amino acid substitution in the V3 region of the human immunodeficiency virus type 1 env protein alters the cellular host range and antigenic structure of the virus. J. Virol. 68:1994;7689-7696.
32. Smith T. W., DeGirolami U., Henin D., Bolgert F., Hauw J. J. Human immunodeficiency virus (HIV) leukoencephalopathy and the microcirculation. J. Neuropathol. Exp. Neurol. 49:1990;357-370.
33. Speck R. F., Wehrly K., Platt E. J., Atchison R. E., Charo I. F., Kabat D., Chesebro B., Goldsmith M. A. Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop. J. Virol. 71:1997;7136-7139.
34. Takeuchi Y., Akutsu M., Murayama K., Shimizu N., Hoshino H. Host range mutant of human immunodeficiency virus type 1: Modification of cell tropism by a single point mutation at the neutralization epitope in the env gene. J. Virol. 65:1991;1710-1718.
35. Takeuchi Y., Inagaki M., Kobayashi N., Hoshino H. Isolation of human immunodeficiency virus from a Japanese hemophilia B patient with AIDS. Jpn. J. Cancer Res. 78:1989;11-15.
36. Trkola A., Dragic T., Arthos J., Binley J. M., Olson W. C., Allaway G. P., Cheng-Mayer C., Robinson J., Maddon P. J., Moore J. P. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature. 384:1996;184-187.
37. Westermark B., Ponten J., Hugosson R. Determinants for the establishment of permanent tissue culture lines from human gliomas. Acta Pathol. Microbiol. Scand. 81:1973;791-805.
38. Willy R. L., Theodore T. S., Martin M. A. Amino acid substitutions in the human immunodeficiency virus type 1 gp120 V3 loop that change viral tropism also alter physical and functional properties of the virion envelope. J. Virol. 68:1994;4409-4419.
39. Wong-Staal F., Gallo R. C., Chang N. T., Ghrayeb J., Papas T. S., Lautenberger J. A., Pearson M. I., Petteway S. R. Jr., Ivanoff L., Baumeister K., Whitehorn E. A., Rafalski J. A., Doran E. R., Josephs S. J., Starcich B., Livak K. J., Patarca R., Haseltine W. A., Ratner L. Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature. 313:1985;277-284.
40. Yi Y., Rana S., Turner J. D., Gaddis N., Collman R. G. CXCR-4 is expressed by primary macrophages and supports CCR5-independent infection by dual-tropic but not T-tropic isolates of human immunodeficiency virus type 1. J. Virol. 72:1998;772-777.